[Pre-Aug 2018] IMSCAR
- Safe Gwe / Cyhoeddiad Gwe › Ymchwil
- Cyhoeddwyd
Improving Outcomes for People with Sarcoma - Analysis of Potential Economic Impact.
Linck, P. G., Linck, P., Hughes, D. A. & Edwards, R. T., 22 Maw 2006Allbwn ymchwil: Ffurf annhestunol › Safe Gwe / Cyhoeddiad Gwe
- Cyhoeddwyd
Improving Outcomes in Children and Young People with Cancer: Analysis of the Potential Economic Impact of the Guidance.
Linck, P. G., Linck, P., Tunnage, B., Hughes, D. A. & Edwards, R. T., 24 Awst 2005Allbwn ymchwil: Ffurf annhestunol › Safe Gwe / Cyhoeddiad Gwe
- Cyhoeddwyd
Investigating factors influencing user choices to visit either general practitioners or community pharmacists in the management of minor ailments – piloting a discrete choice experiment
Hughes, D., Hughes, D. A., Myles, S., Longo, M. & Lisles, C., 1 Maw 2008Allbwn ymchwil: Ffurf annhestunol › Safe Gwe / Cyhoeddiad Gwe
- Papur Gwaith › Ymchwil
- Cyhoeddwyd
Measuring Later Life Social Exclusion in Understanding Society
MacLeod, C., Ross, A., Windle, G., Netuveli, G. & Sacker, A., 27 Meh 2016, The International Centre for Lifecourse Studies in Society and Health (ICLS): University College London, t. 1-14, 14 t.Allbwn ymchwil: Papur gweithio › Papur Gwaith
- Adoddiad Arall › Ymchwil › Heb ei adolygu gan gymheiriaid
- Cyhoeddwyd
The evaluation of the National Exercise Referral Scheme in Wales
Murphy, S. M., Raisanen, L., Moore, G., Edwards, R., Linck, P., Hounsome, N., Williams, N., Din, N. & Moore, L., 2010, Welsh Government. (Social research; Rhif Number: 07/2010)Allbwn ymchwil: Llyfr/Adroddiad › Adoddiad Arall
- Adroddiad Comisiwn › Ymchwil › Adolygwyd gan gymheiriaid
- Cyhoeddwyd
Byw yn dda yn hirach: Y ddadl economaidd dros fuddsoddi yn iechyd a llesiant pobl hŷn yng Nghymru
Edwards, R., Spencer, L., Bryning, L. & Anthony, B., 30 Gorff 2018, 68 t.Allbwn ymchwil: Llyfr/Adroddiad › Adroddiad Comisiwn › adolygiad gan gymheiriaid
- Cyhoeddwyd
Living Well for Longer: Economic argument investing in the health and wellbeing of older people in Wales
Edwards, R., Spencer, L., Bryning, L. & Anthony, B., 30 Gorff 2018, 68 t.Allbwn ymchwil: Llyfr/Adroddiad › Adroddiad Comisiwn › adolygiad gan gymheiriaid
- Cyhoeddwyd
Lles mewn gwaith: Y dadleuon economaidd dros fuddsoddi mewn iechyd a lles y gweithlu yng Nghymru
Edwards, R. T., Spencer, L., Anthony, B. & Bryning, L., 17 Hyd 2019, Bangor : Bangor University. 64 t.Allbwn ymchwil: Llyfr/Adroddiad › Adroddiad Comisiwn › adolygiad gan gymheiriaid
- Cyhoeddwyd
Transforming Young Lives across Wales: The Economic Argument for Investing in Early Years
Edwards, R., Bryning, L. & Lloyd Williams, H., 13 Hyd 2016, Prifysgol Bangor University. 110 t.Allbwn ymchwil: Llyfr/Adroddiad › Adroddiad Comisiwn › adolygiad gan gymheiriaid
- Cyhoeddwyd
Wellness in work: The economic arguments for investing in the health and wellbeing of the workforce in Wales
Edwards, R. T., Spencer, L., Anthony, B. & Bryning, L., 17 Hyd 2019, Bangor: Bangor University. 64 t.Allbwn ymchwil: Llyfr/Adroddiad › Adroddiad Comisiwn › adolygiad gan gymheiriaid
- Adroddiad Comisiwn › Ymchwil › Heb ei adolygu gan gymheiriaid
- Cyhoeddwyd
A pilot clinical trial looking at the effect on lung cancer diagnosis of giving a chest X-Ray to smokers aged over 60 with chest symptoms: National Awareness and Early Diagnosis Initiative (NAEDI) Research Call Funding Partners Report
Neal, R., Edwards, R., Yeo, S. T., Hurt, C. & The ELCID Team, Awst 2015Allbwn ymchwil: Llyfr/Adroddiad › Adroddiad Comisiwn
- Cyhoeddwyd
A review of economic models for second-line chemotherapy in the management of advanced, metastatic breast cancer.
Hughes, D. & Hughes, D. A., 1 Ion 2001, 2001 gol. Unknown.Allbwn ymchwil: Llyfr/Adroddiad › Adroddiad Comisiwn
- Cyhoeddwyd
A study of the effects of the Carers Strategy in Wales on the needs of carers and the services they receive
Seddon, D., Robinson, C. A., Russell, I. T., Woods, R. T., Tommis, Y., Reeves, C., Perry, J. K. & Boyle, M., 1 Ion 2007, 2007 gol. Unknown.Allbwn ymchwil: Llyfr/Adroddiad › Adroddiad Comisiwn
- Cyhoeddwyd
AWMSG criteria for appraising new medicines.
Hughes, D. & Hughes, D. A., 1 Ion 2007, 2007 gol. Unknown.Allbwn ymchwil: Llyfr/Adroddiad › Adroddiad Comisiwn
- Cyhoeddwyd
All Wales Medicines Strategy Group Final Appraisal Report - Abacavir 600mg/lamivudine 300mg (Kivexa) in antiretroviral combination therapy for the treatment of Human Immunodeficiency Virus infection in adults and adolescents from 12 years of age.
Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Ion 2008, 2008 gol. Unknown.Allbwn ymchwil: Llyfr/Adroddiad › Adroddiad Comisiwn
- Cyhoeddwyd
All Wales Medicines Strategy Group Final Appraisal Report - Alemtuzumab (MabCampath) for the treatment of patients with B-cell chronic lymphocytic leukaemia for whom fludarabine combination chemotherapy is not appropriate.
Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Ion 2008, 2008 gol. Unknown.Allbwn ymchwil: Llyfr/Adroddiad › Adroddiad Comisiwn
- Cyhoeddwyd
All Wales Medicines Strategy Group Final Appraisal Report - Ambrisentan (Volibris) for pulmonary arterial hypertension.
Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Ion 2009, 2009 gol. Unknown.Allbwn ymchwil: Llyfr/Adroddiad › Adroddiad Comisiwn
- Cyhoeddwyd
All Wales Medicines Strategy Group Final Appraisal Report - Anidulafungin (Ecalta) for the treatment of invasive candidiasis in adult non-neutropenic patients.
Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Ion 2009, 2009 gol. Unknown.Allbwn ymchwil: Llyfr/Adroddiad › Adroddiad Comisiwn
- Cyhoeddwyd
All Wales Medicines Strategy Group Final Appraisal Report - Atazanavir (Reyataz) in treatment-experienced patients.
Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Ion 2008, 2008 gol. Unknown.Allbwn ymchwil: Llyfr/Adroddiad › Adroddiad Comisiwn
- Cyhoeddwyd
All Wales Medicines Strategy Group Final Appraisal Report - Atazanavir (Reyataz) in treatment-naïve patients.
Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Ion 2008, 2008 gol. Unknown.Allbwn ymchwil: Llyfr/Adroddiad › Adroddiad Comisiwn
- Cyhoeddwyd
All Wales Medicines Strategy Group Final Appraisal Report - Buprenorphine/naloxone (Suboxone) as substitution treatment for opioid dependence.
Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Ion 2008, 2008 gol. Unknown.Allbwn ymchwil: Llyfr/Adroddiad › Adroddiad Comisiwn
- Cyhoeddwyd
All Wales Medicines Strategy Group Final Appraisal Report - Deferasirox (Exjade) for the treatment of chronic iron overload due to blood transfusions.
Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Ion 2008, 2008 gol. Unknown.Allbwn ymchwil: Llyfr/Adroddiad › Adroddiad Comisiwn
- Cyhoeddwyd
All Wales Medicines Strategy Group Final Appraisal Report - Docetaxel (Taxotere) for locally advanced squamous cell carcinoma of the head and neck.
Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Ion 2008, 2008 gol. Unknown.Allbwn ymchwil: Llyfr/Adroddiad › Adroddiad Comisiwn
- Cyhoeddwyd
All Wales Medicines Strategy Group Final Appraisal Report - Emtricitabine/tenofovir DF (Truvada)
Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Ion 2007, 2007 gol. Unknown.Allbwn ymchwil: Llyfr/Adroddiad › Adroddiad Comisiwn
- Cyhoeddwyd
All Wales Medicines Strategy Group Final Appraisal Report - Epoetin delta (Dynepo)
Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Ion 2008, 2008 gol. Unknown.Allbwn ymchwil: Llyfr/Adroddiad › Adroddiad Comisiwn